Source: ERJ Open Res, 7 (1) 00365-2020; 10.1183/23120541.00365-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Juan Antonio Franco-Peláez, Laura Esteban-Lucia, María de los Ángeles Zambrano Chacón, Ana María Pello-Lázaro, Ana María Venegas Rodriguez, Luis Nieto Roca, Camila Sofia García-Talavera, Andrea Kallmeyer Mayor, Felipe Villar Alvarez, Ricardo Fernandez Roblas, Oscar Gonzalez-Lorenzo, José Tuñón, Borja Ibañez, Alvaro Aceña. Statin use is associated with reduced mortality after respiratory viral infection. ERJ Open Res, 7 (1) 00365-2020; 10.1183/23120541.00365-2020

Member's Comments

No comment yet.

Related content which might interest you: Enhanced severity of virus associated asthma exacerbations is not associated with delayed viral clearance and increased viral load Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005 Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Factors associated and attack rate in adenovirus infection among children with chronic respiratory disease Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011 Impact of viral load on mortality in hospitalized patients affected by Covid-19 infection. Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 COPD as an additional risk factor for cardiovascular and respiratory events in patients with respiratory viral infection Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 The risk of mycobacterial infections associated with inhaled corticosteroid use Source: Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017 Year: 2017 Relation between respiratory diseases and the development of cardiovascular events in patients with respiratory viral infection Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 COPD and respiratory viral infections as risk factors for the development of cardiovascular events Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Respiratory syncitial virus infection in hospitalized Brazilian infants with acute lower respiratory disease: incidence and associated factors Source: Eur Respir J 2005; 26: Suppl. 49, 628s Year: 2005 Potential causes of increased long-term mortality after pneumonia Source: Eur Respir J 2011; 37: 1306-1307 Year: 2011 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children? Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008 Predictors of in-hospital mortality in influenza infection. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Impact of bacterial co-infection with COVID-19 on morbidity and mortality Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with advanced HIV disease Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis Year: 2019 Risk factors for bacterial infection in exacerbated COPD requiring admission Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001